EU Adds New COVID-19 Manufacturing Capacity
EU Adds New COVID-19 Manufacturing Capacity
GALWAY, IRELAND--September 7, 2021--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--The European Union (EU) expects to boost the availability of leading COVID-19 vaccines by more than 460 million doses this year after granting permission for new manufacturing capacity in France, Germany and the U.S.
Within this article: Details new plant permits, companies involved, expected boost in vaccine numbers
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Novo Nordisk Spends $11 Billion to Make More Weight Loss Drugs
- EU and AstraZeneca Strike Deal to End Vaccine Row
- Europe Clears Extra COVID-19 Manufacturing Sites to Boost Supplies
- Pfizer-BioNTech, Moderna and Johnson & Johnson Ramp Up COVID-19 Vaccines fo...
- Pfizer/BioNTech Promise Extra 75 Million COVID-19 Vaccine Doses for EU